Keyphrases
Tumor
100%
Aromatase Inhibitors
100%
Antiestrogen
100%
Letrozole
83%
Estrogen
33%
Breast Cancer Patients
16%
Breast Cancer Cells
16%
Estrogen Receptor-positive
16%
Nude Mice
16%
Postmenopausal Breast Cancer
16%
Duration of Response
16%
Tumor Model
16%
Aromatase Gene
16%
Ovariectomized
16%
Aromatization
16%
Matrigel
16%
Resistance Development
16%
Anastrozole
16%
Fulvestrant
16%
Estrogen-dependent Breast Cancer
16%
Duration of Effect
16%
Alternating Treatment
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tamoxifen
100%
Aromatase Inhibitor
100%
Antiestrogen
100%
Neoplasm
66%
Letrozole
55%
Breast Cancer
22%
Mouse
22%
Estrogen Receptor
11%
Tumor Model
11%
Nude Mouse
11%
Aromatase
11%
Matrigel
11%
Anastrozole
11%
Fulvestrant
11%